It's been mentioned before that some (includin myself) that we...

It's been mentioned before that some (includin myself) that we can expect IIb interim trial data this year. I posted a while back that having talked to MR he said it would be next year not this year.

That was a bummer I thought. Turns out that it was a speculative comment in one of the analyst reports that triggered expectations that seem somewhat dashed now.

However, I really do think think that 2012 is going to be a rewarding year for most shareholders (obviously less so if you got in at around 40+, though still for those I think) if planet Eath stays in one piexe and we don't an Independence Day style visit from hostile aliens returning the Mayan civilisation to their home planet!

IIb interim data will be next year and may even be in Q2 if not Q1 (MR didnsay 1st half). Prima's own announcements and website indicate interim III data will be out by Dec 2012. So within 2012 we'll have first clear insight into both trials' progress.

Add to that updates from Dubai about sales and progress of patients using CVac there, world markets settling down (hopefully), early commercialisation plans for Aus/Nz, oral HPV update, we must surely be ready to see brand new highs with a secure floor.

I still have a couple of years or three to wait for Prima, but I think that a bounce due to market rebound will come first followed by a bigger push up after simply because the company will be making progress toward their goal and bringing in revenues same time. Bring in revenues is a changer and will wake up some heavy docile wallets.

Above all else I think by Dec next year, off the back of 2 market updates showing trial data, Prima will be a darling blooming stock well worth holding.

The light at the end of the tunnel is coming, just keep stepping forward.
Every day we are getting closer.